Anti-adalimumab antibodies in juvenile idiopathic arthritis: frequent association with loss of response

被引：30

作者：

Skrabl-Baumgartner, A. ^{[1
]}

Erwa, W. ^{[2
]}

Muntean, W. ^{[1
]}

Jahnel, J. ^{[1
]}

机构：

[1] Med Univ Graz, Dept Paediat & Adolescent Med, Auenbruggerpl 34-2, A-8036 Graz, Austria

[2] Med Univ Graz, Inst Med & Chem Lab Diagnost, A-8036 Graz, Austria

来源：

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2015年 / 44卷 / 05期

关键词：

DISEASE-ACTIVITY SCORE; RHEUMATOID-ARTHRITIS; PEDIATRIC-PATIENTS; IMMUNOGENICITY; METHOTREXATE; EFFICACY; AGENTS;

D O I：

10.3109/03009742.2015.1022213

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objectives: We aimed to determine how loss of response (LOR) to adalimumab (ADA) in juvenile idiopathic arthritis (JIA) may be related to anti-ADA antibodies (AAA). Method: AAA and ADA levels were measured in 23 consecutive patients with JIA responding significantly to treatment with ADA. Results: Six out of 23 (26%) patients developed AAA and had low ADA levels. Five out of six AAA-positive patients experienced LOR. In these patients use of concomitant methotrexate (MTX) was significantly lower. Conclusions: The occurrence of AAA is a frequent event associated with LOR. Monitoring of AAA and serum ADA levels should be considered in JIA patients under ADA therapy.

引用

页码：359 / 362

页数：4

共 50 条

[41] Adalimumab in the Treatment of Uveitis in Juvenile Idiopathic Arthritis
Thorne, Jennifer E.
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (17): : 1682 - 1683
[42] Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: two case reports
Grossi, Valentina
Infantino, Maria
Manfredi, Mariangela
Basile, Umberto
Gulli, Francesca
Marino, Mariapaola
Li Gobbi, Francesca
Damiani, Arianna
Atzeni, Fabiola
Benucci, Maurizio
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (04) : E105 - E108
[43] Therapeutic drug monitoring of adalimumab in RA: no predictive value of adalimumab serum levels and anti-adalimumab antibodies for prediction of response to the next bDMARD
Ulijn, Evy
den Broeder, Nathan
Wientjes, Maike
van Herwaarden, Noortje
Meek, Inger
Tweehuysen, Lieke
van der Maas, Aatke
van den Bemt, Bart J. F.
den Broeder, Alfons A.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (07) : 867 - 873
[44] Quantitative evaluation of adalimumab and anti-adalimumab antibodies in sera using a surface plasmon resonance biosensor
Di Santo, Andrea
Accinno, Matteo
Errante, Fosca
Capone, Manuela
Vultaggio, Alessandra
Simoncini, Eleonora
Zipoli, Giuditta
Cosmi, Lorenzo
Annunziato, Francesco
Rovero, Paolo
Fernandez, Feliciana Real
CLINICAL BIOCHEMISTRY, 2024, 133
[45] The influence of anti-adalimumab antibodies on adalimumab through levels, TNF-α levels and clinical outcome
Bodini, G.
Giannini, E.
Pellegatta, G.
Demarzo, G.
Marabotto, E.
Furnari, M.
Baldissarro, I.
Savarino, V.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 88 - 88
[46] Anti-skin anti-intercellular antibodies in juvenile idiopathic arthritis
Hromadnikova, I.
Vavrincova, P.
Stechova, K.
Hridelova, D.
Vavrinec, J.
ARTHRITIS RESEARCH & THERAPY, 2001, 3 (Suppl 2)
[47] ASSOCIATION OF CLINICAL EFFICACY WITH SERUM LEVEL OF ADALIMUMAB (ADA) AND ANTI-ADALIMUMAB ANTIBODY LEVELS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (RA)
Avdeeva, A. S.
Aleksandrova, E. N.
Novikov, A. A.
Karateev, D. E.
Luchihina, E. L.
Cherkasova, M. V.
Nasonov, E. L.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 927 - 927
[48] Anti-skin anti-intercellular antibodies in juvenile idiopathic arthritis
I Hromadnikova
P Vavrincova
K Stechova
D Hridelova
J Vavrinec
Arthritis Research & Therapy, 3
[49] THE INFLUENCE OF ANTI-ADALIMUMAB ANTIBODIES ON ADALIMUMAB THROUGH LEVELS, TNF-α LEVELS AND CLINICAL OUTCOME
Bodini, G.
Savarino, V.
Dulbecco, P.
Baldissarro, I.
Savarino, E.
DIGESTIVE AND LIVER DISEASE, 2015, 47 : E94 - E95
[50] The influence of anti-adalimumab antibodies on adalimumab trough levels, TNF-α levels and clinical outcome
Bodini, G.
Savarino, V.
Dulbecco, P.
Baldissarro, I.
Savarino, E.
JOURNAL OF CROHNS & COLITIS, 2014, 8 : S42 - S42

← 1 2 3 4 5 →